Silveira et al. showed that the introduction of a transgenic B cell receptor (BCR) specific for the disease-irrelevant antigen, hen egg lysozyme (HEL), in the NOD.Igμ mouse delayed T1D development and prevented T cell proliferation [8]. The gene discussed is BCR; the disease is type 1 diabetes mellitus.